The proposed bill, if enacted, would amend existing Arizona statutes to prohibit health care insurers from imposing cost-sharing requirements for diagnostic prostate cancer screenings for high-risk subscribers starting January 1, 2027. This change would apply to various types of insurers, including hospital service corporations, medical service corporations, disability insurers, and group disability insurers. The bill defines "high-risk" individuals as men who are at least 55 years old, carry the breast cancer gene (BRCA1 or BRCA2), have a family history of prostate cancer, or are military veterans exposed to agent orange.

In addition to the prohibitions, the bill clarifies the definition of "high-risk" by detailing the criteria for family history, which includes having a first-degree relative diagnosed with prostate cancer, who died from it, developed a related cancer, or was diagnosed with a genetic mutation associated with increased prostate cancer risk. The amendments would be inserted into various sections of Title 20 of the Arizona Revised Statutes, enhancing protections for high-risk individuals regarding prostate cancer screenings.

Statutes affected:
Introduced Version: 20-841.14, 20-1057.21, 20-1376.11, 20-1406.11